Workshop on Monoclonal Antibodies in Cancer
October 1, 2010
Hyatt Regency Washington on Capitol Hill
Washington, D.C.
Program Schedule
To view slides from a presenter click the  icon next to the presentation title.
Friday, October 1, 2010
|
|
8:00 am - 8:15 am |
Welcome & Overview: Monoclonal Antibodies in Cancer
George J. Weiner, MD - University of Iowa |
|
8:15 am - 10:05 am |
Session 1: Tumor-Targeted Antibodies
Chair: Ira Mellman, PhD - Genentech, Inc.
Targeting Activated HER2 in Solid Tumors
Mark X. Sliwkowski, PhD - Genentech, Inc.
Monoclonal Antibody Immunotherapy
Louis M. Weiner, MD - Georgetown University Medical Center
Combining Tumor-Reactive mAbs with Cytokines to Induce ADCC in Patients
Paul M. Sondel, MD, PhD - University of Wisconsin, Madison
|
|
10:30 am - 12:00 pm |
Session 2: Immunomodulatory Antibodies
Chair: Glenn Dranoff, MD - Dana-Farber Cancer Institute
Immune Modulation by Antibody
Lieping Chen, MD, PhD - Johns Hopkins University School of Medicine
Immunomodulation with Antibodies Blocking the B7-H1/PD-1 Axis
Suzanne L. Topalian, MD - Johns Hopkins University School of Medicine
|
|
1:00 pm - 2:30 pm |
Session 3: Investigating Antibodies as "Vaccines"
Chair: Ira Mellman, PhD - Genentech, Inc.
Antibody Therapeutics in Cancer: Converting Passive to Active
Raphael Clynes, MD, PhD - Colubmia University
Antibody-Targeted Vaccines
Tibor Keler, PhD - Celldex Therapeutics, Inc. |
|
3:00 pm - 5:00 pm |
Session 4: Antibody Engineering
Chair: George J. Weiner, MD - University of Iowa
Two-in-One Antibody: From Proof-of-Concept to Therapeutic Candidate
Germaine Fuh - Genentech, Inc.
Engineered Anti-Cancer Antibodies with Enhanced Effector Functions
Pablo Umaña, PhD - Roche Glycart AG
T Cell-Engaging Antibodies for Cancer Therapy
Patrick A. Baeuerle, PhD - Micromet, Inc. |
|
|
|
Saturday, October 2 - Monday, October 4
|
iSBTc 25th Annual Meeting
For more information, please click here. |
|
|
|
